Alumis - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeAlumis
Alumis logo

Alumis

0 followers

ALMS

Performance

About Alumis

Alumis is a biotechnology company focused on developing therapies for immune-mediated diseases. Based in the San Francisco Bay Area, it advances a late-stage portfolio of targeted, precision therapeutics designed to improve patient outcomes across conditions such as lupus and psoriasis. The company emphasizes integrating scientific insights with a proprietary data analytics platform to accelerate therapeutic development. Alumis’ leadership and operations are anchored in South San Francisco, California.

Recent News

Recent Deals

No recent deals for this company.

Key Facts

HQ Location

South San Francisco, United States

Founded

2021

Employees

51 - 200

Status

Public

Website

https://alumis.com